Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Cancer Epidemiology|January 13, 2021
The impact of excluding or including Death Certificate Initiated (DCI) cases on estimated cancer survival: A simulation studyTherese M-L Andersson, Tor Åge Myklebust, Mark J Rutherford, et al.
British Journal of Cancer|December 9, 2020
Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation studyTherese M-L Andersson, Mark J Rutherford, Tor Åge Myklebust, et al.
The Lancet. Gastroenterology & Hepatology|May 21, 2019
Changes in colorectal cancer incidence in seven high-income countries: a population-based studyMarzieh Araghi, Isabelle Soerjomataram, Aude Bardot, et al.
Thorax|February 13, 2013
Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007Sarah Walters, Camille Maringe, Michel P Coleman, et al.
Lancet (London, England)|February 4, 2018
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countriesClaudia Allemani, Tomohiro Matsuda, Veronica Di Carlo, et al.
Gut|June 20, 2020
International trends in oesophageal cancer survival by histological subtype between 1995 and 2014Eileen Morgan, Isabelle Soerjomataram, Anna T Gavin, et al.
Gut|June 3, 2020
Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project)Marzieh Araghi, Melina Arnold, Mark J Rutherford, et al.
Gynecologic Oncology|February 2, 2020
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based studyCitadel J Cabasag, John Butler, Melina Arnold, et al.
Gut|November 26, 2021
International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study)Melina Arnold, Eileen Morgan, Aude Bardot, et al.
The Lancet. Oncology|September 16, 2019
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based studyMelina Arnold, Mark J Rutherford, Aude Bardot, et al.
Pageof 10